152 related articles for article (PubMed ID: 1290821)
1. [The effect of MPTP on the neuronal uptake of monoamines].
Burov IuV; Trapkova AA; Malakhova VB; Metkalova SE; Maĭsov NI
Biull Eksp Biol Med; 1992 Nov; 114(11):492-4. PubMed ID: 1290821
[TBL] [Abstract][Full Text] [Related]
2. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
3. 4,4-Diphenylpiperidine derivates and their sila analogues. A comparative study of their interaction with neural receptor biding sites and synaptosomal monoamine uptake.
Stasch JP; Russ H; Schacht U; Witteler M; Neuser D; Gerlach M; Leven M; Kuhn W; Jutzi P; Przuntek H
Arzneimittelforschung; 1988 Aug; 38(8):1075-8. PubMed ID: 2848535
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of the inhibiting effect of atypical antidepressants and psychostimulants on the synaptosomal uptake of monoamines].
Gankina EM; Maĭsov NI
Biull Eksp Biol Med; 1983 Aug; 96(8):52-4. PubMed ID: 6224517
[TBL] [Abstract][Full Text] [Related]
5. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
[TBL] [Abstract][Full Text] [Related]
6. [Effect of reserpine on monoamine uptake by rat brain synaptosomes].
Blaschke M; Fischer HD; Rudolph E
Acta Biol Med Ger; 1980; 39(11-12):1205-12. PubMed ID: 7245989
[TBL] [Abstract][Full Text] [Related]
7. Single low dose of MPTP decreases extracellular levels of noradrenaline and monoamine metabolites in the ventrobasal thalamus of the rats.
Nyitrai G; Kékesi KA; Dobolyi A; Pungor K; Juhász G
Neurobiology (Bp); 1997; 5(2):249-61. PubMed ID: 9302709
[TBL] [Abstract][Full Text] [Related]
8. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes.
Tuomisto J; Tuomisto L
Med Biol; 1980 Feb; 58(1):33-7. PubMed ID: 7382578
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of the effect of psychotropic preparations on the synaptosomal uptake of monoamines].
Maĭsov NI; Gankina EM; Voronina TA
Farmakol Toksikol; 1985; 48(4):46-50. PubMed ID: 4043363
[TBL] [Abstract][Full Text] [Related]
10. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the serotonergic system in the mode of action of the new potential antidepressant agent 5-methoxyindolyl-2-methylamine.
Carranza Gómez-Carpintero MC; Ochoa Estomba MC
Arzneimittelforschung; 1993 Aug; 43(8):809-13. PubMed ID: 8216432
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
Ofori S; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
[TBL] [Abstract][Full Text] [Related]
13. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue.
Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP; Murphy F; Neumeyer JL
Life Sci; 1986 Nov; 39(19):1765-77. PubMed ID: 3490612
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
[TBL] [Abstract][Full Text] [Related]
15. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
16. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
Pifl C; Hornykiewicz O; Giros B; Caron MG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
[TBL] [Abstract][Full Text] [Related]
17. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
18. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects.
Jarvis MF; Wagner GC
Synapse; 1990; 5(2):104-12. PubMed ID: 2309157
[TBL] [Abstract][Full Text] [Related]
19. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Schmidt N; Ferger B
Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
